Litigation Details for ASTRAZENECA AB v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2014)
✉ Email this page to a colleague
ASTRAZENECA AB v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-12-16 |
| Court | District Court, D. New Jersey | Date Terminated | 2016-10-14 |
| Cause | 35:271 Patent Infringement | Assigned To | Mary Little Cooper |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Parties | AKTIEBOLAGET HASSLE | ||
| Patents | 6,369,085; 7,411,070; 8,466,175 | ||
| Attorneys | RAVIN R. PATEL | ||
| Firms | McCarter and English, LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASTRAZENECA AB v. ACTAVIS LABORATORIES FL, INC.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for ASTRAZENECA AB v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-12-16 | 1 | the ’504 patent expires on August 3, 2015. 13. United States Patent No. 6,369,085 (“the ’085… products covered by United States Patent Nos. 5,714,504; 6,369,085; 7,411,070; and 8,466,175. … The Patents-in-Suit 11. United States Patent No. 5,714,504 (“the ’504 patent”), entitled…formulations patented in the ’504 patent, is a material for use in practicing the methods patented in the ’…compounds patented in the ’085 patent, is a material for use in practicing the methods patented in the ’ | External link to document | |
| 2015-06-05 | 12 | Actavis admits that United States Patent No. 6,369,085 (the “’085 patent”) is entitled “Form of S-Omeprazole…Actavis admits that United States Patent No. 5,714,504 (“the ’504 patent”) is entitled “Compositions,” was… 1998 and, according to the patent assignment database at the U.S. Patent and Trademark Office, was assigned… 2002 and, according to the patent assignment database at the U.S. Patent and Trademark Office, was assigned…Actavis admits that United States Patent No. 7,411,070 (the “’070 patent”) is entitled “Form of S-Omeprazole | External link to document | |
| 2015-06-26 | 17 | claims of U.S. Patent Nos. 5,714,504 (the “’504 patent”); 6,369,085 (the “’085 patent”); 7,411,070 (… (the “’070 patent”); and 8,466,175 (the “’175 patent”) (collectively, the “patents-in- suit”). Plaintiffs… purports to state a cause of action under the patent laws of the United States, 35 U.S.C. § 1, et seq…respect to the ’504, ’192, ’085, ’872, and ’070 patents. Plaintiffs deny the remaining allegations of …with respect to the ’504, ’085, ’070, and ’175 patents. Plaintiffs deny the remaining allegations of | External link to document | |
| 2014-12-17 | 2 | Astra Aktiebolag 2 US 6,369,085 B1 4/9/2002 … PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK…Pleading PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK… ____ Trademarks or X Patents. ( ____ the patent action involves 35 U.S.C. § 292.) DOCKET… AO120 Patent Form filed. (mak) (Entered: 12/22/2014) 17 December 2014 PACER Document | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
